DR. REDDY'S LABORATORIES-ADR (RDY) Stock Analyst Ratings

NYSE:RDY • US2561352038

14.36 USD
-0.22 (-1.51%)
Last: Feb 27, 2026, 12:14 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

67

ChartMill assigns a Buy % Consensus number of 67% to RDY. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 15.63. This target is 8.85% above the current price.
  • RDY was analyzed by 44 analysts. The buy percentage consensus is at 67. So analysts seem to be have mildly positive about RDY.
  • In the last month the buy percentage rose by 10 points. So the trust of analysts is improving.
  • RDY was analyzed by 44 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Find peers with buy consensus above 85%
RDY Historical Analyst RatingsRDY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30 40

Price Target & Forecast

Price Low Median Mean High 14.3611.9015.2615.6319.52 - -17.11% 6.28% 8.85% 35.91%

Related screens

Find peers 30% below price target
RDY Current Analyst RatingRDY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-06-05 HSBC Upgrade Hold -> Buy
2024-11-06 Barclays Maintains Overweight -> Overweight
2024-07-30 Barclays Maintains Overweight -> Overweight
2024-05-08 Barclays Maintains Overweight -> Overweight
2024-01-29 Barclays Maintains Overweight -> Overweight
2023-06-01 Barclays Maintains Overweight -> Overweight
2022-10-31 Barclays Maintains Overweight
2022-10-25 Barclays Maintains Overweight
2022-09-12 Barclays Maintains Overweight
2022-07-25 Barclays Maintains Overweight
2022-05-24 Barclays Maintains Overweight
2021-11-01 Barclays Maintains Overweight
2021-07-28 Prabhudas Lilladher Maintains Accumulate
2021-07-28 Axis Direct Maintains Buy
2021-07-28 ICICI Securities Limited Maintains Hold
2021-07-28 Motilal Oswal Maintains Neutral
2021-07-27 Axis Direct Maintains Buy
2021-06-23 Axis Direct Maintains Buy
2021-05-19 Geojit BNP Paribas Maintains Buy
2021-05-17 Axis Direct Maintains Buy
2021-05-17 HDFC Securities Maintains Accumulate
2021-05-17 SMC online Maintains
2021-05-15 Prabhudas Lilladher Maintains Accumulate
2021-05-15 ICICI Securities Limited Maintains Hold
2021-05-15 Motilal Oswal Maintains Neutral
2021-04-13 Axis Direct Maintains Buy
2021-03-10 Nirmal Bang Maintains Buy
2021-03-10 Nirmal Bang Institutional Maintains Buy

DR. REDDY'S LABORATORIES-ADR / RDY FAQ

What is the average price target for DR. REDDY'S LABORATORIES-ADR (RDY) stock?

44 analysts have analysed RDY and the average price target is 15.63 USD. This implies a price increase of 8.85% is expected in the next year compared to the current price of 14.36.


What is the consensus rating for RDY stock?

The consensus rating for DR. REDDY'S LABORATORIES-ADR (RDY) is 67.2727 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


How many analysts have analysed DR. REDDY'S LABORATORIES-ADR (RDY)?

The number of analysts covering DR. REDDY'S LABORATORIES-ADR (RDY) is 44.